Ortho Clinical Diagnostics (NASDAQ:OCDX) and Parallax Health Sciences (OTCMKTS:PRLX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.
Earnings & Valuation
This table compares Ortho Clinical Diagnostics and Parallax Health Sciences' top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Ortho Clinical Diagnostics | N/A | N/A | N/A | N/A | N/A |
Parallax Health Sciences | N/A | N/A | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent recommendations for Ortho Clinical Diagnostics and Parallax Health Sciences, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Ortho Clinical Diagnostics | 0 | 1 | 11 | 0 | 2.92 |
Parallax Health Sciences | 0 | 0 | 0 | 0 | N/A |
Ortho Clinical Diagnostics currently has a consensus target price of $24.2727, indicating a potential upside of 25.12%. Given Ortho Clinical Diagnostics' higher possible upside, equities research analysts plainly believe Ortho Clinical Diagnostics is more favorable than Parallax Health Sciences.
Profitability
This table compares Ortho Clinical Diagnostics and Parallax Health Sciences' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Ortho Clinical Diagnostics | N/A | N/A | N/A |
Parallax Health Sciences | N/A | N/A | N/A |
Summary
Ortho Clinical Diagnostics beats Parallax Health Sciences on 2 of the 2 factors compared between the two stocks.